Related Experiment Videos
Limiting ischemic myocardial damage using glucose-insulin-potassium solutions
1Department of Cardiothoracic Surgery, Boston University Hospital, MA 02118, USA.
The Annals of Thoracic Surgery
|August 1, 1995
Summary
Glucose-insulin-potassium (GIK) infusion during revascularization significantly reduces myocardial damage. GIK treatment lessened tissue acidosis and necrosis, improving heart function post-procedure.
Area of Science:
- Cardiology
- Experimental Medicine
- Biochemistry
Background:
- Myocardial damage during revascularization is a significant clinical concern.
- Investigating protective strategies for ischemic heart tissue is crucial.
Purpose of the Study:
- To evaluate the efficacy of glucose-insulin-potassium (GIK) solution in mitigating myocardial damage during coronary revascularization.
- To compare different GIK administration timings and routes.
Main Methods:
- A porcine model with induced coronary occlusion and reperfusion was used (n=40).
- Groups received varying GIK infusion protocols (intravenous, coronary sinus, pre-treatment, reperfusion only) or no GIK (control).
- Myocardial damage assessed via echocardiography (wall motion), tissue pH, and infarct size.
Main Results:
- All GIK-treated groups exhibited reduced tissue acidosis and improved wall motion scores compared to the unmodified group.
- The GIK-Pre and GIK-CS groups showed the least myocardial necrosis (14% and 12%, respectively) versus 73% in the unmodified group (p < 0.05).
- GIK administration significantly reduced infarct size across all treatment arms.
Conclusions:
- Glucose-insulin-potassium solution effectively reduces ischemic myocardial damage during coronary revascularization.
- Pre-treatment and coronary sinus GIK infusion appear most beneficial in limiting infarct size.